- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Viratech Acquires 50% of Newswire.net, in Spin Off of Cancer.im, Inc.
Viratech (OTCPINK:VIRA) announced the acquisition of an additional 35,000,000 shares of common stock of Newswire, Inc., in exchange for all the issued and outstanding shares of Cancer.im, Inc. As quoted in the press release: “The Company’s efforts over the last 3 years have been focused on developing a social network platform, focused on capturing a multi …
Viratech (OTCPINK:VIRA) announced the acquisition of an additional 35,000,000 shares of common stock of Newswire, Inc., in exchange for all the issued and outstanding shares of Cancer.im, Inc.
As quoted in the press release:
“The Company’s efforts over the last 3 years have been focused on developing a social network platform, focused on capturing a multi perspective point of view via verified and vetted social collaboration,” stated Fred Schiemann CEO of Viratech. “With this announcement we have hit a milestone; first with this transaction, we gain a partner in Newswire, where we hope to harness Newswire’s distribution platform to promote our News as a Utility (NaaU) Engine.
“Second, we have achieved our Minimum Viable Product (MVP) threshold, on developing our first SNAP to reside on the www.cancer.imdomain on March 15, 2017. With the sale of Cancer.im, Inc. property, Viratech can now focus on developing new SNAP’s in the other health verticals. That is the beauty of software, once the infrastructure is built, replication into other health verticals becomes easier.”
“Viratech has engineered an amazing tool-set for the cancer community, and starting March 15, 2017, I am excited that our team will be able to curate, manage and produce some of the most relevant content on the web pertaining to cancer research,” stated Chris Ryan CEO of Cancer.im, Inc.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.